HT-3951 vs. Placebo in Stroke Rehabilitation

Summary

This is a randomized, double-blind, placebo-controlled parallel group outpatient study that will utilize standard stroke rehabilitation outcome measures, as well as fMRI techniques in a subset of subjects, to evaluate the effect of HT-3951 on motor recovery and behavior in medically stable subjects following ischemic stroke.

Timeline

Start

2016-02

Primary completion

2017-12-31

Completion

2017-12-31

Outcome

Outcome not reported

Stopped: “Administrative”

Drugs

Indications